Alpha-1 antitrypsin deficiency: A conformational disease associated with lung and liver manifestations

Journal of Inherited Metabolic Disease

Volumn 31, Issue 1, 2008, Pages 21-34

  Greene, C M ^a   Miller, S D W ^a   Carroll, T ^a   McLean, C ^a   O'Mahony, M ^a   Lawless, M W ^b   O'Neill, S J ^a   Taggart, C C ^c   McElvaney, N G ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; ALPHA 1 ANTITRYPSIN; CASTANOSPERMINE; GLUTAMIC ACID; GLYCEROL; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENT; LACTACYSTIN; LYSINE; PARVOVIRUS VECTOR; PROTEINASE INHIBITOR; RETINOIC ACID; TRIMETHYLAMINE OXIDE;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; AMINO ACID SUBSTITUTION; AUTOPHAGY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE COURSE; DRUG SYNTHESIS; EMPHYSEMA; ENDOPLASMIC RETICULUM; ENZYME BLOOD LEVEL; GENE MUTATION; HUMAN; LIVER CELL; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG DISEASE; MONOTHERAPY; NONHUMAN; PROTEIN FOLDING; RESPIRATORY EPITHELIUM; REVIEW; RNA INTERFERENCE;

EID: 46549087438     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0748-y     Document Type: Review

References (112)

1. Banner BF, Karamitsios N, Smith L, et al (1998) Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C. Am J Gastroenterol 93: 1541-1545.
2. Bell H, Schrumpf E, Fagerhol MK (1990) Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease. Scand J Gastroenterol 25: 788-792.
3. Bergwitz C, Brabant G, Trautwein C, Manns MP (2002) A patient with autoimmune hepatitis type I, Addison's disease, atrophic thyroiditis, atrophic gastritis, exocrine pancreatic insufficiency, and heterozygous alpha1-antitrypsin deficiency. Am J Gastroenterol 97: 1050-1052.
4. Bowlus CL, Willner I, Zern MA, et al (2005) Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol 3: 390-396.
5. Brantly ML, Paul LD, Miller BH, et al (1988) Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 138: 327-336.
6. Burrows JA, Willis LK, Perlmutter DH (2000) Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci U S A 97: 1796-1801.
7. Cadene M, Duranton J, North A, et al (1997) Inhibition of neutrophil serine proteinases by suramin. J Biol Chem 272: 9950-9955.
8. Cantor JO, Cerreta JM, Keller S, et al (1995) Modulation of airspace enlargement in elastase-induced emphysema by intratracheal instillment of hyaluronidase and hyaluronic acid. Exp Lung Res 21: 423-436.
9. Cantor JO, Cerrata JM, Armand G, et al (1998) Aerosolized hyaluronic acid decreases alveolar injury induced by human neutrophil elastase. Proc Soc Exp Biol Med 217: 471-475.
10. Carlson JA, Rogers BB, Sifers RN, et al (1988) Multiple tissues express alpha 1 antitrypsin in transgenic mice and man. J Clin Invest 82: 26-36.
11. Carrell RW (1986) Alpha 1-Antitrypsin: Molecular pathology, leukocytes, and tissue damage. J Clin Invest 78: 1427-1431.
12. Carrell RW, Lomas DA (2002) Alpha-1-antitrypsin deficiency - a model for conformational diseases. New Engl J Med 346: 45-53.
13. Casolaro MA, Fells G, Wewers M, et al (1987) Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin. J Appl Physiol 63: 2015-2023.
14. Cox DW (1999) α1-antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS et al, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 2409-2437.
15. Cox DW, Mansfield T (1987) Prenatal diagnosis of alpha-1 antitrypsin deficiency and estimates of fetal risk for disease. J Med Genet 24: 52-59.
16. Cruz PE, Mueller C, Cossette TL, et al (2007) In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA. Lab Invest 87: 893-902.
17. Crystal RG (1998) Alpha-1-antitrypsin deficiency, emphysema and liver disease: Genetic basis and strategies for therapy. J Clin Invest 85: 1343-1352.
18. Curiel DT, Chytil A, Courtney M, et al (1989) Serum alpha-1-antitrypsin deficiency associated with the common S-type (glu264-to-val) mutation results from intracellular degradation of alpha-1-antitrypsin prior to secretion. J Biol Chem 264: 10477-10486.
19. Czaja AJ (1998) Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis. Dig Dis Sci 43: 1725-1731.
20. Darlington GJ, Astrin KH, Muirhead SP, et al (1982) Assignment of human alpha 1 antitrypsin to chromosome 14 by somatic cell hybrid analysis. Proc Natl Acad Sci U S A 79: 870-873.
21. Dawson LJ, Guest PJ, Stockley RA (2002) The relationship of chronic sputum expectoration to physiologic, radiologic, and ealth status characteristics in alpha(1)-antitrypsin deficiency (PiZ). Chest 122: 1247-1255.
22. de Serres FJ (2002) Worldwide racial and ethnic distribution of 1-antitrypsin deficiency. Summary of an analysis of published genetic epidemiology surveys. Chest 122: 1818-1829.
23. Devlin GL, Parfrey H, Tew DJ, Lomas DA, Bottomley SP (2001) Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency. Am J Respir Cell Mol Biol 24: 727-732.
24. Edwards PD, Bernstein PR (1994) Synthetic inhibitors of elastase. Med Res Rev 14: 127-194.
25. Eigenbrodt ML, McCashland TM, Dy RM, Clark J, Galati J (1997) Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease. Am J Gastroenterol 92: 602-607.
26. Elliott PR, Bilton D, Lomas DA (1998) Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol 18: 670-674.
27. Elzouki AN, Verbaan H, Lindgren S, Widell A, Carlson J, Eriksson S (1997) Serine protease inhibitors in patients with chronic viral hepatitis. J Hepatol 27: 42-48.
28. Eriksson S (1963) Pulmonary emphysema and alpha-1-antitrypsin deficiency. Acta Med Scand 175: 197-205.
29. Flotte TR (2002) Recombinant adeno-associated virus gene therapy for cystic fibrosis and alpha(1)-antitrypsin deficiency. Chest 121: 98-102S.
30. Fraizer GC, Harrold TR, Hofker MH, et al (1989) In-frame single codon deletion in the M(Malton) deficiency allele of alpha-1-antitrypsin. Am J Hum Genet 44: 894-902.
31. Gadek JE, Crystal RG (1983) Alpha 1-Antitrypsin deficiency. In: Stanbury JB, Wyngaarden JB, Frederickson DS, et al, eds. The Metabolic Basis of Inherited Disease. New York: McGraw Hill, 1450-1467.
32. Gishen P, Saunders AJS, Tobin MJ, et al (1982) Alpha-1 antitrypsin deficiency: The radiological features of pulmonary emphysema in subjects of Pi-type Z and Pi-type SZ: A survey by the British Thoracic Association. Clin Radiol 33: 371-377.
33. Guest PJ, Hansell DM (1992) High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol 45: 260-266.
34. Harding HP, Zhang Y, Bertolotti A, et al (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 5: 897-904.
35. Harding HP, Calfon M, Urano F, et al (2002) Transcriptional and translational control in the Mammalian unfolded protein response. Annu Rev Cell Dev Biol 18: 575-599.
36. Hidvegi T, Schmidt BZ, Hale P, et al (2005) Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response. J Biol Chem 280: 39002-39015.
37. Hinds R, Hadchouel A, Shanmugham NP, et al (2006) Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin deficiency-related liver disease. J Pediatr Gastroenterol Nutr 43: 136-138.
38. Hosokawa N, Tremblay LO, You Z, et al (2003) Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong alpha1-antitrypsin by human ER mannosidase I. J Biol Chem 278: 26287-26294.
39. Hubbard RC, Crystal RG (1990) Strategies for aerosol therapy of alpha-1-antitrypsin deficiency by the aerosol route. Lung 168: 565-578.
40. Hubbard RC, Brantly ML, Sellers SE, et al (1989) Anti-neturophil elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. Ann Intern Med 111: 206-212.
41. Hutchison DC (1998) Alpha-1 antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z. Respir Med 92: 367-377.
42. Janciauskiene S, Dominaitiene R, Sternby NH, et al (2002) Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. J Biol Chem 277: 26540-26546.
43. Janciauskiene S, Larsson S, Larsson P, et al (2004) Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin. Biochem Biophys Res Commun 321: 592-600.
44. Jiang HY, Wek SA, McGrath BC, et al (2004) Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol 24: 1365-1377.
45. Kawabata K, Suzuki M, Sugitani M, et al (1991) ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 177: 814-820.
46. Knorre A, Wagner M, Schaefer HE, et al (2002) DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs. Biol Chem 383: 271-282.
47. Kok KF, Wahab PJ, Houwen RH, et al (2007) Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: A review. Neth J Med 65: 160-166.
48. Kopito RR (1997) ER quality control: The cytoplasmic connection. Cell 88: 427-430.
49. Kudo T, Katayama T, Imaizumi K, et al (2002) The unfolded protein response is involved in the pathology of Alzheimer's disease. Ann N Y Acad Sci 977: 349-355.
50. Laurell CB, Eriksson S (1963) The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. Scand J Clin Lab Invest 15: 132-140.
51. Lawless MW, Greene CM, Mulgrew A, et al (2004) Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency. J Immunol 172: 5722-5726.
52. Lawless MW, Mankan AK, White M, et al (2007) Expression of hereditary hemochromatosis C282Y HFE protein in HEK293 cells activates specific endoplasmic reticulum stress responses. BMC Cell Biol 8: 30.
53. Lomas DA, Evans DL, Finch JT, et al (1992) The mechanism of Z alpha-1-antitrypsin accumulation in the liver. Nature 357: 605-607.
54. Luisetti M, Sturani C, Sella D, et al (1996) MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled clinical trial. Eur Respir J 9: 1482-1486.
55. Ma Y, Brewer JW, Diehl JA, et al (2002) Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J Mol Biol 318: 1351-1365.
56. Mahadeva R, Dafforn TR, Carrell RW, et al (2002) 6-Mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem 277: 6771-6774.
57. Mao JT, Goldin JG, Dermand J, et al (2002) A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med 165: 718-723.
58. Marcus NY, Perlmutter DH (2000) Glucosidase and mannosidase inhibitors mediate increased secretion of mutant alpha1 antitrypsin Z. J Biol Chem 275: 1987-1992.
59. Massi G (1996) Pathogenesis and pathology of liver disease associated with alpha 1 antitrypsin deficiency. Chest 110: 251S-255S.
60. McElvaney NG, Feuerstein I, Simon TR, et al (1989) Comparison of the relative sensitivity of routine pulmonary function tests, scintigraphy, and computerised axial tomography in detecting early lung disease associated with α1-antitrypsin deficiency. Am Rev Respir Dis 139: A122.
61. McElvaney NG, Stoller JK, Buist AS, et al (1997) Baseline characteristics of enrolees in the National Heart, Lung and Blood Institute Registry of alpha-1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest 111: 394-403.
62. Miller SD, Greene CM, McLean C, et al (2007) Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1 antitrypsin via inhibition of bad. Hepatology 46: 496-503.
63. Miranda E, Romisch K, Lomas DA (2004) Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. J Biol Chem 279: 28283-28291.
64. Molmenti EP, Perlmutter DH, Rubin DC (1993) Cell-specific expression of alpha 1 antitrypsin in human intestinal epithelium. J Clin Invest 92: 2022-2034.
65. Mori K (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101: 451-454.
66. Mulgrew AT, Taggart CC, Lawless MW, et al (2004) Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 125: 1952-1957.
67. Novoradovskaya N, Lee J, Yu ZX, et al (1998) Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency. J Clin Invest 101: 2693-2701.
68. Oda Y, Hosokawa N, Wada I, et al (2003) EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 299: 1394-1397.
69. Owen MC, Brennan SO, Lewis JH, et al (1983) Mutation of antitrypsin to antithrombin-1 antitrypsin Pittsburgh (358-Met Arg), a fatal bleeding disorder. N Engl J Med 309: 694-698.
70. Ozaki I, Zern MA, Liu S, Wei DL, Pomerantz RJ, Duan L (1999) Ribozyme-mediated specific gene replacement of the alpha1-antitrypsin gene in human hepatoma cells. J Hepatol 31: 53-60.
71. Parfrey H, Mahadeva R, Ravenhill NA, et al (2003) Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease. J Biol Chem 278: 33060-33066.
72. Pauwels RA, Buist AS, Calverley PM, et al (2001) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163: 1256-1276.
73. Perlmutter DH (2002) Liver injury in alpha1-antitrypsin deficiency: An aggregated protein induces mitochondrial injury. J Clin Invest 110: 1579-1583.
74. Piitulainen E, Sveger T (2002) Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ). Thorax 57: 705-708.
75. Pittschieler K (2001) Rare alpha-1-antitrypsin phenotypes and liver-test abnormalities during infancy. Acta Paediatr 90: 406-408.
76. Pittulainen E, Carlson J, Ohlsson K, Sveger T (2005) Alpha-1 antitrypsin deficiency in 26-year-old subjects: Lung, liver, and protease/protease inhibitor studies. Chest 128: 2076-2081.
77. Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W (1992) High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Ann Intern Med 117: 641-645.
78. Psacharopoulos HT, Mowat AP, Cook PJ, et al (1983) Outcome of liver disease associated with alpha-1- antitrypsin deficiency (PiZ). Implications for genetic counselling and antenatal diagnosis. Arch Dis Child 58: 882-887.
79. Rakela J, Goldschmiedt M, Ludwig J (1987) Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency. Dig Dis Sci 32: 1358-1362.
80. Ralston DR, Marsh CB, Lowe MP, et al (1997) Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 100: 1416-1424.
81. Ranes J, Stoller JK (2005) A review of alpha-1 antitrypsin deficiency. Semin Respir Crit Care Med 26: 154-166.
82. Rogers J, Kalsheker N, Wallis S, et al (1983) The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes. Biochem Biophys Res Commun 116: 375-382.
83. Ron D (2002). Translational control in the endoplasmic reticulum stress response. J Clin Invest 110: 1383-1388.
84. Rouhani F, Paone G, Smith NK, et al (2000) Lung neutrophil burden correlates with increased pro-inflammatory cytokines and decreased lung function in individuals with alpha(1)-antitrypsin deficiency. Chest 117: 250S-251S.
85. Rudnick DA, Perlmutter DH (2005) Alpha-1-antitrypsin deficiency: A new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 42: 514-521.
86. Schmidt BZ, Perlmutter DH (2005) Grp78, Grp94, and Grp170 interact with alpha1-antitrypsin mutants that are retained in the endoplasmic reticulum. Am J Physiol Gastrointest Liver Physiol 289: G444-455.
87. Schroder M, Kaufman RJ (2005) ER stress and the unfolded protein response. Mutat Res 569: 29-63.
88. Schroeder WT, Miller MF, Woo SL, et al (1985) Chromosomal localization of the human alpha 1-antitrypsin gene (PI) to 14q31-32. Am J Hum Genet 37: 868-872.
89. Scott BB, Egner W (2006) Does alpha1-antitrypsin phenotype PiMZ increase the risk of fibrosis in liver disease due to hepatitis C virus infection? Eur J Gastroenterol Hepatol 18: 521-523.
90. Sharp HL, Bridges RA, Krivit W, et al (1969) Cirrhosis associated with alpha-1 antitrypsin deficiency: A previously unrecognized inherited disorder. J Lab Clin Med 73: 934-939.
91. Sharp HL, Mathis R, Krivit W, et al (1971) The liver in noncirrhotic alpha-1-antitrypsin deficiency. J Lab Clin Med 78: 1012-1013.
92. Sharp LK, Mallya M, Kinghorn KJ, et al (2006) Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis. FEBS J 273: 2540-2552.
93. Silverman EK, Pierce JA, Province MA, et al (1989) Variability of pulmonary function in alpha-1-antitrypsin deficiency: Clinical correlates. Ann Intern Med 111: 982-991.
94. Simon TR, McElvaney NG, Feuerstein I, et al (1989) Quantitative comparison of V-Q and CT for identifying emphysema in α1-antitrypsin deficiency. J Nucl Med 30: 10.
95. Sokol RJ, Balistreri WF, Hoofnagle JH, et al (1985) Vitamin E deficiency in adults with chronic liver disease. Am J Clin Nutr 41: 66-72.
96. Song S, Morgan M, Ellis T, et al (1998) Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A 95: 14384-14388.
97. Sveger T (1976) Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 294: 1316-1321.
98. Sveger T, Eriksson S (1995) The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology 22: 514-517.
99. Teckman JH, Perlmutter DH (2000) Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 279: G961-974.
100. Teckman JH, Gilmore R, Perlmutter DH (2001a) Role of ubiquitin in proteasomal degradation of mutant alpha(1)-antitrypsin Z in the endoplasmic reticulum. Am J Physiol Gastrointest Liver Physiol. 278: G39-48
101. Teckman JH, Burrows J, Hidvegi T, Schmidt B, Hale PD, Perlmutter DH (2001b) The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem 276: 44865-44872.
102. Teckman JH, An JK, Loethen S, et al (2002) Fasting in alpha1-antitrypsin deficient liver: Constitutive activation of autophagy. Am J Physiol Gastrointest Liver Physiol 283: G1156-1165.
103. Teckman JH, An JK, Blomenkamp K, et al (2004) Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency. Am J Physiol Gastrointest Liver Physiol 286: G851-862.
104. Tobin MJ, Cook PJL, Hutchinson DC (1983) Alpha-1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. Br J Dis Chest 77: 14-27.
105. Travers KJ, Patil CK, Wodicka L, et al (2000) Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101: 249-258.
106. Wall M, Moe E, Eisenberg J, et al (1990) Long term follow up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr 116: 248-251.
107. Wewers MD, Casolaro MA, Sellers SE, et al (1987) Replacement therapy for alpha1-antitrypsin deficiency associated with emphysema. N Engl J Med 316: 1055-1062.
108. Williams JC, Falcone RC, Knee C, et al (1991) Biologic characterization of ICI200,800 and ICI 200,355, novel inhibitors of human neutrophil elastase. Am Rev Respir Dis 144: 875-883.
109. Wright G, Carver A, Cottom D, et al (1991) High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep. Biotechnology (NY) 9: 830-834.
110. Yoshida H, Matsui T, Yamamoto A, et al (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881-891.
111. Yoshida H, Matsui T, Hosokawa N, et al (2003) A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell 4: 265-271.
112. Ziomek CA (1998) Commercialization of proteins produced in the mammary gland. Theriogenology 49: 139-144.